FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions relates to the field of medicine and pharmaceutics and includes following inventions: 1) a parenteral liquid composition as an anticonvulsant, including a carbamate compound of the formula 1 or its pharmaceutically acceptable salt or hydrate and a cyclodextrin derivative selected from 2-hydroxypropyl-β-cyclodextrin or sulfobutyl ester of β-cyclodextrin:
[Formula 1]
,
where R1 and R2, each independently, are selected from a group consisting of hydrogen, halogen and C1-C8 alkyl; and one of A1 and A2 is CH, and another is N, where a mass ratio of an active ingredient and cyclodextrin derivative is from 1:5 to 1:40; 2) an injection composition including the specified ingredients and a pharmaceutically acceptable solvent for injections; 3) a method for producing a parenteral liquid composition, including mixing of the specified carbamate compound and cyclodextrin derivative. The carbamate compound is preferably (R)-1-(2-chlorphenyl)-2-tetrazole-2-yl)ethyl ester of carbamic acid.
EFFECT: group of inventions provides for the creation of liquid compositions of carbamate compounds of the formula 1 having increased stability and solubility of the active agent.
6 cl, 1 dwg, 3 tbl, 3 ex
Title |
Year |
Author |
Number |
CARBAMATE COMPOUND AND THE USE OF A COMPOSITION CONTAINING IT FOR THE PREVENTION, RELIEF OR TREATMENT OF ACUTE STRESS DISORDER OR POST-TRAUMATIC STRESS DISORDER |
2019 |
- Ryu, Eun Ju
- Maeng, Cheol Young
- Shin, Hye Won
|
RU2796295C2 |
USE OF CARBAMATE COMPOUND FOR PREVENTION, RELIEF OR TREATMENT OF TREMORS OR TREMOR SYNDROME |
2017 |
- Yoo, Jin Uk
- Lee, Hye Sung
- Yi, Han Ju
|
RU2776368C2 |
USE OF CARBAMIC ACID COMPOUND FOR PREVENTION OR TREATMENT OF FIBROMYALGIA OR FUNCTIONAL SYNDROME ASSOCIATED WITH FIBROMYALGIA |
2017 |
- Jo, Min Jae
- Yi, Han Ju
- Hwang, Sun Gwan
|
RU2753525C2 |
USE OF A CARBAMATE COMPOUND FOR THE REDUCTION OR TREATMENT OF DEVELOPMENTAL DISORDERS INCLUDING FRAGILE X SYNDROME, ANGELMANN SYNDROME, OR RETT SYNDROME |
2018 |
- Shin, Hye Won
- Hwang, Sun Gwan
|
RU2793742C2 |
COMPLEX OF RAS-FARNESYLTRANSFERASE INHIBITOR, COMPOSITION OF RAS-FARNESYLT RANSFERASE INHIBITOR, PHARMACEUTICAL COMPOSITION |
1999 |
- Radzhkhavan Krishnasvami S.
- Mehlloi Timoti M.
- Vehria Sehjlesh A.
|
RU2230062C2 |
MIXTURE CONTAINING CARBAMATE COMPOUND FOR PREVENTION, RELIEF OR TREATMENT OF SCHIZOPHRENIA |
2018 |
- Joung, Chan Mi
- Hwang, Sun Gwan
- Lee, Ji Won
- Jang, Young Koo
|
RU2772465C2 |
USE OF CARBAMATE DERIVATIVE FOR PREVENTION, RELIEF, OR TREATMENT OF MINOR EPILEPTIC SEIZURE OR EPILEPSY SHOWING MINOR EPILEPTIC SEIZURE |
2018 |
|
RU2787771C2 |
PURIFIED DERIVATIVES OF SULFOALKYL ETHERS OF CYCLODEXTRINE OR THEIR MIXTURE, CLATRATE COMPLEX OF CYCLODEXTRINE DERIVATIVES WITH MEDICINAL, AND PHARMACEUTICAL COMPOSITION |
1993 |
- Valentino Zh.Stella
- Rodzher Raevski
|
RU2113442C1 |
COMPOSITIONS WHICH CONTAIN EPOTHILONE, AND METHOD OF THEIR OBTAINING |
2005 |
- Reer Olaf
- Rents Mattias
- Zakhze Andreas
- Shprenger Klaudia
- Tomsen Jens
- Uffrekht Anka
|
RU2416407C2 |
ANTIMICROBIAL PRESERVATIVES FOR OBTAINING MULTIDOZE COMPOUNDINGS USING β-CYCLODEXTRINES FOR LIQUID MEDICINAL FORMS |
2005 |
- Adami Rodzher Kristofer
- David Frederik
- Vud Dzhulija Ehnn
|
RU2332997C2 |